Alzamend Neuro Meets Nasdaq Standards, Embraces Social Media

Alzamend Neuro (ALZN) just unveiled an update.

Alzamend Neuro, Inc. successfully regained compliance with Nasdaq’s Minimum Bid Price Requirement after its stock price closed below $1.00 for 30 consecutive days, which had initially put the company at risk of delisting. The company also announced plans to utilize various social media platforms, including Facebook, Instagram, LinkedIn, and others, to communicate key information to investors, alongside traditional channels like SEC filings and press releases. This approach aligns with their commitment to transparency and the need to satisfy disclosure obligations, although they caution investors about the inherent risks in forward-looking statements.

Learn more about ALZN stock on TipRanks’ Stock Analysis page.